News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gentronix Limited Signs Three Year Agreement with GlaxoSmithKline (GSK) for GreenScreen HC and BlueScreen HC Genotoxicity Assays


3/3/2010 10:38:26 AM

MANCHESTER, UK--(BUSINESS WIRE)--Gentronix Limited Manchester, UK announced today that it has entered into a three year agreement with GlaxoSmithKline (GSK) to provide GreenScreen HC and BlueScreen HC genotoxicity assays for use by GSK in genotoxicity screening.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES